Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy
Advanced Materials · 2023-05 · 35 (21)
DOI: 10.1002/adma.202300439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 31.03.2023. Verfasst von Hong Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, Sichuan university, Chengdu, 610064, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Atherosclerosis, Photoacoustic Techniques. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National 111 Project of Introducing Talents of Discipline to Universities, Scientific Fund of Sichuan Province.
Abstract (Originalsprache)
The culprits of atherosclerosis are endothelial damage, local disorders of lipid metabolism, and progressive inflammation. Early atherosclerosis is typically difficult to diagnose in time due to the lack of obvious symptoms, thus missing the best period of treatment. In this work, a π‐conjugated polymer (PMeTPP‐MBT) based on 3,6‐bis(4‐methylthiophen‐2‐yl)‐2,5‐bis(2‐octyldodecyl)pyrrolo[3,4‐c]pyrrole‐1,4(2H,5H)‐dione is designed as a novel photoacoustic contrast agent. On this basis, an intelligent responsive theranostic nanoplatform (PA/ASePSD) combining astaxanthin and SS‐31 peptide and loading with PMeTPP‐MBT is developed. The high affinity between the dextran shell with the broken endothelial surface VCAM‐1 and CD44 confers active targeting of PA/ASePSD to atherosclerotic lesions. High levels of ROS in the acidic plaque microenvironment act as an intelligent cascade switch to achieve controlled release of astaxanthin, SS‐31 peptide, and PMeTPP‐MBT for non‐invasive photoacoustic diagnosis, as well as plaque inhibition mediated by anti‐inflammation and multichannel regulation (including ABCA1, ABCG1, CD36, and LOX‐1) of lipid metabolism. Both in vitro and in vivo evaluations confirm the impressive anti‐atherosclerotic capability and the accurate photoacoustic diagnosis of PA/ASePSD nanoparticles, thus promising a candidate for early‐stage atherosclerosis theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, Sichuan university, Chengdu, 610064, P. R. China.
- Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, P. R. China.
- Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, 310016, P. R. China.
ORCID-Profile: Hong Xu, Yunbing Wang
Förderung
- National Natural Science Foundation of China
- National 111 Project of Introducing Talents of Discipline to Universities
- Scientific Fund of Sichuan Province
- Sichuan Science and Technology Major Project
Zitieren
APA
Xu, H., She, P., Zhao, Z., Ma, B., Li, G., & Wang, Y. (2023). Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy. Advanced Materials, 35(21). https://doi.org/10.1002/adma.202300439
Vancouver
Xu H, She P, Zhao Z, Ma B, Li G, Wang Y. Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy. Advanced Materials. 2023;35(21). doi:10.1002/adma.202300439
BibTeX
@article{Xu2023,
author = {Xu, Hong and She, Peiyi and Zhao, Zhiyu and Ma, Boxuan and Li, Gaocan and Wang, Yunbing},
title = {Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {21},
doi = {10.1002/adma.202300439}
}
EUVIMED